Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:CVET

Covetrus (CVET) Stock Price, News & Analysis

Covetrus logo

About Covetrus Stock (NASDAQ:CVET)

Key Stats

Today's Range
$20.99
$20.99
50-Day Range
$20.87
$20.99
52-Week Range
$13.39
$21.20
Volume
3 shs
Average Volume
1.34 million shs
Market Capitalization
$2.94 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.

Receive CVET Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covetrus and its competitors with MarketBeat's FREE daily newsletter.

CVET Stock News Headlines

CVET Historical Data
Financial Prophecy
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.
See More Headlines

CVET Stock Analysis - Frequently Asked Questions

Covetrus, Inc. (NASDAQ:CVET) announced its earnings results on Sunday, February, 28th. The company reported $0.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.05. Covetrus's revenue was up 11.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Covetrus investors own include Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Netflix (NFLX), Advanced Micro Devices (AMD), Alphabet (GOOG) and Home Depot (HD).

Company Calendar

Last Earnings
2/28/2021
Today
11/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Drug Stores & Proprietary Stores
Sub-Industry
N/A
Current Symbol
NASDAQ:CVET
Fax
N/A
Employees
5,710
Year Founded
N/A

Profitability

Net Income
$-54,000,000.00
Pretax Margin
-0.56%

Debt

Sales & Book Value

Annual Sales
$4.58 billion
Cash Flow
$2.19 per share
Book Value
$10.97 per share

Miscellaneous

Free Float
139,563,000
Market Cap
$2.94 billion
Optionable
Not Optionable
Beta
1.51
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (NASDAQ:CVET) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners